These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 18507151

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [In vitro activity of fluconazole, voriconazole and posaconazole against Candida spp].
    Rubio Calvo MC, Gil J, Ramírez de Ocáriz I, Benito R, Rezusta A.
    Rev Esp Quimioter; 2003 Jun; 16(2):227-32. PubMed ID: 12973462
    [Abstract] [Full Text] [Related]

  • 28. [Biofilm production and antifungal susceptibility patterns of Candida species].
    Yücesoy M, Karaman M.
    Mikrobiyol Bul; 2004 Jun; 38(1-2):91-8. PubMed ID: 15293907
    [Abstract] [Full Text] [Related]

  • 29. Evaluation of antifungal susceptibility testing in Candida isolates by Candifast and disk-diffusion method.
    Giri S, Kindo AJ.
    Indian J Pathol Microbiol; 2014 Jun; 57(4):595-7. PubMed ID: 25308014
    [Abstract] [Full Text] [Related]

  • 30. Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis.
    Yang YL, Ho YA, Cheng HH, Ho M, Lo HJ.
    Infect Control Hosp Epidemiol; 2004 Jan; 25(1):60-4. PubMed ID: 14756222
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Evaluation of Mycograb, amphotericin B, caspofungin, and fluconazole in combination against Cryptococcus neoformans by checkerboard and time-kill methodologies.
    Nooney L, Matthews RC, Burnie JP.
    Diagn Microbiol Infect Dis; 2005 Jan; 51(1):19-29. PubMed ID: 15629225
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Emergence of non-albicans Candida species and antifungal resistance in a tertiary care hospital.
    Capoor MR, Nair D, Deb M, Verma PK, Srivastava L, Aggarwal P.
    Jpn J Infect Dis; 2005 Dec; 58(6):344-8. PubMed ID: 16377864
    [Abstract] [Full Text] [Related]

  • 36. In vitro growth-inhibitory activity of pneumocandins L-733,560 and L-743,872 against putatively amphotericin B- and fluconazole-resistant Candida isolates: influence of assay conditions.
    Nelson PW, Lozano-Chiu M, Rex JH.
    J Med Vet Mycol; 1997 Dec; 35(4):285-7. PubMed ID: 9292427
    [Abstract] [Full Text] [Related]

  • 37. The trend of susceptibilities to amphotericin B and fluconazole of Candida species from 1999 to 2002 in Taiwan.
    Yang YL, Li SY, Cheng HH, Lo HJ, TSARY Hospitals.
    BMC Infect Dis; 2005 Nov 03; 5():99. PubMed ID: 16266438
    [Abstract] [Full Text] [Related]

  • 38. In vitro susceptibility of 115 isolates of Candida to amphotericin B, fluconazole and itraconazole.
    Mallié M, Bastide JM.
    Drugs Exp Clin Res; 1996 Nov 03; 22(6):301-7. PubMed ID: 9034756
    [Abstract] [Full Text] [Related]

  • 39. [In vitro susceptibility of Candida strains to fluconazole and amphotericin B].
    Fernández Andreu CM, Martínez Machin G, Illnait Zaragozi MT, Perurena Lancha MR, Aguila Sánchez A, Galloso Brito M.
    Rev Cubana Med Trop; 2007 Nov 03; 59(2):113-8. PubMed ID: 23427444
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.